These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 4444228)

  • 21. [Review on internal medicine, 1973--nephrology. 6. Calcium metabolism in patients on regular dialysis treatment (author's transl)].
    Ogura Y
    Nihon Naika Gakkai Zasshi; 1974 Apr; 63(4):353-63. PubMed ID: 4605927
    [No Abstract]   [Full Text] [Related]  

  • 22. [Vitamin A metabolism in dialysis patients--are dialysis patients poisoned by vitamin A? (author's transl)].
    Kawaguchi S; Maeda K; Yamamoto A; Kobayshi K
    Nihon Jinzo Gakkai Shi; 1980 Sep; 22(9):1209-20. PubMed ID: 7193257
    [No Abstract]   [Full Text] [Related]  

  • 23. [Critical evaluation of some laboratory parameters of derangements in calcium, magnesium and phosphorus metabolism in patients treated by chronic intermittent haemodialysis (author's transl)].
    Revúsová V; Zvara V; Gratzlová J; Reznícek J; Borosová E
    Bratisl Lek Listy; 1976 Apr; 65(4):378-83. PubMed ID: 963558
    [No Abstract]   [Full Text] [Related]  

  • 24. [Physical efficiency and metabolic changes in patients treated by periodical dialyses (author's transl)].
    Lisý Z; Tomásek R; Pick P
    Cas Lek Cesk; 1975 Feb; 114(9):263-6. PubMed ID: 1139612
    [No Abstract]   [Full Text] [Related]  

  • 25. Drugs in renal failure: dosing guidelines for frequently used drugs in end-stage renal disease and dialysis patients.
    Seyffart G
    Blood Purif; 1985; 3(1-3):140-68. PubMed ID: 4096834
    [No Abstract]   [Full Text] [Related]  

  • 26. [Use of physical fitness for indirect appreciation of age in dialysed patients (author's transl)].
    Havel V; Erben J
    Z Alternsforsch; 1981; 36(6):537-42. PubMed ID: 7336792
    [No Abstract]   [Full Text] [Related]  

  • 27. [Changes of guanidino compounds in chronic renal failure (author's transl)].
    Shitomoto M; Otsuji S
    Nihon Jinzo Gakkai Shi; 1979 Jan; 21(1):33-49. PubMed ID: 449116
    [No Abstract]   [Full Text] [Related]  

  • 28. [Serum lipids and lecithin cholesterol acyltransferase activity in chronic hemodialysis patients (author's transl)].
    Makise J; Matsuda Y; Hirose N; Hara K; Kijima Y; Shoji T; Kanayama M
    Rinsho Byori; 1979 Mar; 27(3):233-6. PubMed ID: 439472
    [No Abstract]   [Full Text] [Related]  

  • 29. [Treatment of terminal chronic renal failure in Chile: perspectives (author's transl)].
    Morales J
    Rev Med Chil; 1978 Jul; 106(7):571. PubMed ID: 358348
    [No Abstract]   [Full Text] [Related]  

  • 30. [Use of drugs in patients with renal failure (author's transl)].
    Díes F
    Rev Invest Clin; 1979; 31(3):199-209. PubMed ID: 523855
    [No Abstract]   [Full Text] [Related]  

  • 31. Dietary treatment of chronic renal failure.
    Blainey JD; Chamberlain MJ
    Br Med Bull; 1971 May; 27(2):160-4. PubMed ID: 4931762
    [No Abstract]   [Full Text] [Related]  

  • 32. [How long and how often to dialyse patients with chronic renal failure (author's transl)].
    Válek A; Bozek P; Melicharová D; Dzúrik R
    Cas Lek Cesk; 1977 Nov; 116(47):1461-6. PubMed ID: 597832
    [No Abstract]   [Full Text] [Related]  

  • 33. [Aluminium accumulation in patients with chronic renal failure (author's transl)].
    Tsukamoto Y; Marumo F; Iwanami S; Nango H; Higashishiba H; Nakazawa R
    Nihon Jinzo Gakkai Shi; 1980 Jun; 22(6):721-8. PubMed ID: 7206332
    [No Abstract]   [Full Text] [Related]  

  • 34. Glomerular permeability to serum proteins and high molecular weight dextrans in glomerulonephritis.
    Petrie JJ; MacLean PR; Robson JS
    Clin Sci; 1968 Feb; 34(1):83-95. PubMed ID: 5640686
    [No Abstract]   [Full Text] [Related]  

  • 35. [Single injection clearance of alpha-ketoglutarate in chronic renal failure (author's transl)].
    Manz F; Schärer K; Alatas H; Lommel R
    Klin Wochenschr; 1974 Feb; 52(3):143-4. PubMed ID: 4826654
    [No Abstract]   [Full Text] [Related]  

  • 36. [Investigations on oxygen transport in chronic renal insufficiency (author's transl)].
    Siemon G; Wölk G; Thoma R
    Pneumonologie; 1975 Sep; 152(1-3):235-41. PubMed ID: 1187394
    [No Abstract]   [Full Text] [Related]  

  • 37. [Dialysis treatment of renal failure in patients with SLE--the results of nationwide survey in Japan (author's transl)].
    Nagasawa T; Yoshida M; Koyama N
    Nihon Jinzo Gakkai Shi; 1978 Nov; 20(11):1141-7. PubMed ID: 748638
    [No Abstract]   [Full Text] [Related]  

  • 38. [Present and future in the treatment of renal failure (author's transl)].
    Agishi T
    Nihon Hinyokika Gakkai Zasshi; 1980 Oct; 71(10):1168-71. PubMed ID: 7007699
    [No Abstract]   [Full Text] [Related]  

  • 39. [Alteration of beta2-microglobulin metabolism in terminal chronic renal insufficiency (author's transl)].
    Vincent C; Revillard JP; Traeger J
    Pathol Biol (Paris); 1978 Sep; 26(6):303-6. PubMed ID: 83569
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Disturbances of calcium and phosphate metabolism in chronic renal failure].
    Noiri E; Okuda T; Kurokawa K
    Nihon Rinsho; 1992 Jan; 50 Suppl():512-20. PubMed ID: 1578732
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.